Aclidinomycin B
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-00014 |
| CAS | |
| Molecular Weight | 431.44 |
| Molecular Formula | C21H25N3O7 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Aclidinomycin B is a nalidixin antibiotic isolated from the Streptomyces halstedi. Aclidinomycin has anti-gram-positive bacteria and tumor activity.
- Specification
- Properties
- Price Product List
| IUPAC Name | (1R,3R,13S,18S,19S,21S,23R)-5,12-dihydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.02,6.03,21.07,12.014,18.019,23]tricosa-6,9-diene-8,11-dione |
| Canonical SMILES | CC1=C(C(=O)C2=C3C(OC4N3C5C6C(CC4N6C)C7N(C5C2(C1=O)O)CCO7)O)OC |
| InChI | InChI=1S/C21H25N3O7/c1-7-15(29-3)14(25)10-12-20(27)31-19-9-6-8-11(22(9)2)13(24(12)19)16(21(10,28)17(7)26)23-4-5-30-18(8)23/h8-9,11,13,16,18-20,27-28H,4-6H2,1-3H3/t8-,9-,11+,13+,16-,18-,19+,20?,21?/m0/s1 |
| InChI Key | WPPGPABOHAFRPK-YNPOTRRUSA-N |
| Antibiotic Activity Spectrum | Gram-positive bacteria; neoplastics (Tumor) |
| BBF-02594 | Pyrrolnitrin | Inquiry |
| BBF-04609 | 1,1-Dimethylbiguanide hydrochloride | Inquiry |
| BBF-03868 | Honokiol | Inquiry |
| BBF-00693 | Ansamitocin P-3 | Inquiry |
| BBF-04301 | Tulathromycin A | Inquiry |
| BBF-01732 | Mevastatin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
